Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, ...
Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced that it awarded a total of $1.5 million to 28 organiza...
CytoReason, a leader in developing computational disease models for predictive insights, announced today it secured an aggregated $80 million from OurCro...
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media Supports local biopharma manufact...
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, has announced the successful completion of ...
Daiichi Sankyo announced that it has opened a new affiliate for its oncology business in Athens, Greece. The establishment highlights the company&r...
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital...
ChargePoint Technology, a leading specialist in powder containment and aseptic transfer solutions, is expanding its presence in India, and announced...
Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the launch of the ChemiDoc™ Go Im...
The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs The PPD clinical research bu...
Merck, a leading science and technology company, is proud to announce the celebration of its 100th anniversary in Spain. Since opening our first commercial...
Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Thermo Scientific™ KingFisher™ PlasmidPro Maxi Process...
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...
© 2024 Biopharma Boardroom. All Rights Reserved.
